Lewis-Hall Freda C has filed 12 insider transactions across 2 companies since March 2023.
Most recent transaction: a grant/award of 45867 shares of Pyxis Oncology, Inc. ($PYXS) on March 24, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 24, 2026 | Pyxis Oncology, Inc. | $PYXS | Lewis-Hall Freda C | Not found | A | Stock Option (Right to Buy) | 45867 | $0.00 | 45,867.0000 | 62,557,386 | 9999.99% | 0.07% |
| Aug. 5, 2025 | CDT Equity Inc. | $CDT | Lewis-Hall Freda C | Director | A | Stock Option (Right to Buy) | 15000 | $0.00 | 15,000.0000 | 6,662,755 | 9999.99% | 0.23% |
| Aug. 12, 2025 | CDT Equity Inc. | $CDT | Lewis-Hall Freda C | Director | A | Common Stock | 35000 | $0.00 | 40,145.0000 | 6,662,755 | 680.27% | 0.53% |
| March 31, 2025 | Pyxis Oncology, Inc. | $PYXS | Lewis-Hall Freda C | Not found | A | Stock Option (Right to Buy) | 36979 | $0.98 | 36,979.0000 | 58,445,765 | 9999.99% | 0.06% |
| March 30, 2025 | CDT Equity Inc. | $CDT | Lewis-Hall Freda C | Director | A | Common Stock | 47612 | $0.89 | 77,193.0000 | 6,662,755 | 160.95% | 0.71% |
| Dec. 18, 2024 | CDT Equity Inc. | $CDT | Lewis-Hall Freda C | Director | A | Stock Option (Right to Buy) | 420000 | $0.07 | 420,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 18, 2024 | CDT Equity Inc. | $CDT | Lewis-Hall Freda C | Director | A | Common Stock | 437976 | $0.09 | 2,958,287.0000 | 0 | 17.38% | 0.00% |
| April 22, 2024 | CDT Equity Inc. | $CDT | Lewis-Hall Freda C | Director | A | Warrant (Right to buy) | 400664 | $0.00 | 504,061.0000 | 0 | 387.50% | 0.00% |
| April 22, 2024 | CDT Equity Inc. | $CDT | Lewis-Hall Freda C | Director | A | Warrant (Right to buy) | 103397 | $0.00 | 504,061.0000 | 0 | 25.81% | 0.00% |
| March 26, 2024 | Pyxis Oncology, Inc. | $PYXS | Lewis-Hall Freda C | Not found | A | Common Stock | 35219 | $0.00 | 241,405.0000 | 39,904,603 | 17.08% | 0.09% |
| Dec. 1, 2023 | CDT Equity Inc. | $CDT | Lewis-Hall Freda C | Director | A | Stock Option (Right to Buy) | 65000 | $5.51 | 65,000.0000 | 0 | 9999.99% | 0.00% |
| March 24, 2023 | Pyxis Oncology, Inc. | $PYXS | Lewis-Hall Freda C | Director | A | Common Stock | 139355 | $0.00 | 206,186.0000 | 0 | 208.52% | 0.00% |